Baird Maintains Outperform on Healthpeak Properties, Lowers Price Target to $19

Benzinga Newsdesk www.benzinga.com Negative 92.5%

Neg 92.5% Neu 0% Pos 0%

Baird analyst Amanda Sweitzer maintains Healthpeak Properties (NYSE:DOC) with a Outperform and lowers the price target from $20 to $19.